Proactive Investors UK

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia ... News-Medical.net The trial is designed to evaluate the safety and efficacy of sustained erythropoietin ("EPO") therapy delivered via the Company's EPODURE Biopump™ for the treatment of anemia in dialysis patients with end-stage renal disease ("ESRD"). Medgenics files application for Phase II EPODURE trial Proactive Investors UK all 12 news articles »

...